title: Serum lipoprotein (a) in renal transplant recipients treated with cyclosporin monotherapy compared to conventional treatment.
authors.forename: M S
authors.initials: MS
authors.lastname: Islam
authors.forename: J M
authors.initials: JM
authors.lastname: Bard
authors.forename: P
authors.initials: P
authors.lastname: Le Pogamp
authors.forename: D
authors.initials: D
authors.lastname: Leglise
authors.forename: B
authors.initials: B
authors.lastname: Bourbigot
authors.forename: J
authors.initials: J
authors.lastname: Rivalan
authors.forename: J
authors.initials: J
authors.lastname: Cledes
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000009:adverse effects; D016572:Cyclosporine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000209:etiology; D006951:Hyperlipoproteinemias / Q000209:etiology*; D016030:Kidney Transplantation / Q000009:adverse effects*; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D008875:Middle Aged; D013256:Steroids / Q000009:adverse effects
chemical_list: D017270:Lipoprotein(a); D013256:Steroids; D016572:Cyclosporine; D001379:Azathioprine